Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
9.21
-0.12 (-1.29%)
At close: Sep 17, 2025, 4:00 PM EDT
9.39
+0.18 (1.95%)
After-hours: Sep 17, 2025, 5:17 PM EDT
Kodiak Sciences Employees
Kodiak Sciences had 109 employees as of December 31, 2024. The number of employees decreased by 2 or -1.80% compared to the previous year.
Employees
109
Change (1Y)
-2
Growth (1Y)
-1.80%
Revenue / Employee
n/a
Profits / Employee
-$1,833,257
Market Cap
485.40M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 109 | -2 | -1.80% |
Dec 31, 2023 | 111 | -1 | -0.89% |
Dec 31, 2022 | 112 | 19 | 20.43% |
Dec 31, 2021 | 93 | 21 | 29.17% |
Dec 31, 2020 | 72 | 33 | 84.62% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
KOD News
- 2 days ago - New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI) - PRNewsWire
- 15 days ago - Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI) - PRNewsWire
- 21 days ago - Harbour BioMed Reports 2025 Interim Results - PRNewsWire
- 21 days ago - Jim Cramer: Kodiak Sciences Is A 'Pure Spec' Stock, Recommends Buying This Utilities Stock - Benzinga
- 4 weeks ago - Kodiak Sciences to Present at American Chemical Society Fall 2025 - PRNewsWire
- 5 weeks ago - Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Kodiak Sciences to Host Investor R&D Day on July 16, 2025 - PRNewsWire
- 3 months ago - Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular Inflammation Society - PRNewsWire